Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: A TACTICS-TIMI 18 substudy

Journal of the American College of Cardiology

Volumn 40, Issue 10, 2002, Pages 1761-1768

  Sabatine, Marc S ^a   Morrow, David A ^a   Cannon, Christopher P ^a   Murphy, Sabina A ^b   Demopoulos, Laura A ^c   DiBattiste, Peter M ^c   McCabe, Carolyn H ^a   Braunwald, Eugene ^a   Gibson, C Michael ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; TIROFIBAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; BLOOD CLOT LYSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; EVALUATION; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; OUTCOMES RESEARCH; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEES, PHARMACEUTICAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICS; STROKE VOLUME; SURVIVAL ANALYSIS; SYNDROME; TYROSINE;

EID: 0037145886     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02484-1     Document Type: Article

References (29)

1. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-8.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
3. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460-5.
4. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L, for the FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000;343:1139-47.
5. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction. Circulation 2000;102:2329-34.
6. Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E, for the OPUS-TIMI 16 Investigators. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 2001;87:636-9.
7. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary, syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
8. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 2001;286:2405-12.
9. The TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.
10. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88.
11. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125-30.
12. Schlant RC, Forman S, Stamler J, Canner PL. The natural history of coronary heart disease: Prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the Coronary. Drug Project. Circulation 1982;66:401-14.
13. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-26.
14. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary, atherosclerotic plaques is characterized by an inflammatory, process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
16. Libby P, Simon DI. Inflammation and thrombosis: The clot thickens. Circulation 2001;103:1718-20.
17. Marx N, Neumann FJ, Ott I, et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997;30: 165-70.
18. Ott I, Neumann FJ, Kenngott S, Gawaz M, Schomig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 1998;82:938-42.
19. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
20. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999;34: 1420-6.
21. Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword? J Clin Invest 1985;76:1713-9.
22. Toss H, Lindahl B, Siegbahn A, Wailentin L, for the FRISC Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997;96: 4204-10.
23. Heeschen C, Hamm CW, Bruemmer J, Simoons ML, for the CAPTURE Investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. J Am Coll Cardiol 2000;35:1535-42.
24. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107-13.
25. Bhatt DL, Chew DP, Simoons ML, et al. An elevated white blood cell count is an independent predictor of mortality in patients with acute coronary syndromes. Circulation 2000;102 Suppl II:776.
26. Wallentin L, Siegbahn A, Diderholm E, et al. Raised mortality at inflammatory activity or myocardial damage in unstable CAD is reduced by an invasive strategy. Eur Heart J 2000;21 Suppl:246.
27. Cannon CP, Weintraub WS, Demopoulos LA, et al. High-sensitivity C-reactive protein (hs-CRP) to predict 6 month mortality and relative benefit of invasive vs. conservative strategy in patients with unstable angina: Primary results of the TACTICS-TIMI 18 C-Reactive Protein Substudy (abstr). J Am Coll Cardiol 2001;37:315A.
28. Kumar A, Villani MP, Patel UK, Keith JC, Jr., Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999;99:1363-9.
29. Baran KW, Nguyen M, McKendall GR, et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation 2001;104:2778-83.